RXi Pharmaceuticals to Present at Leading Investor and Healthcare Conferences BY PR Newswire — 7:02 AM ET 02/08/2017
MARLBOROUGH, Mass., Feb. 8, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation , a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today announced that Geert Cauwenbergh, Dr. Med. Sc., President and CEO of RXi Pharmaceuticals ( RXII ), will present a corporate overview at two leading industry conferences on February 14th and 16th, 2017 in New York City. The overview will include the Company's proprietary self-delivering RNAi (sd-rxRNA®) platform and the multiple development and commercialization opportunities available across a broad spectrum of therapeutic areas. The Company is honored to have been selected to participate at these premier industry events that provide a platform to present to seasoned business leaders, high-net worth individuals and institutional investors.
19th Annual BIO CEO & Investor Conference Tuesday, February 14, 2017 at 3:00 pm ET, Park South Room The Waldorf Astoria New York
2nd Annual Disruptive Growth and Healthcare Conference Thursday, February 16, 2017 at 12:45 pm ET, Tribeca Room Convene, NYC
The presentations will be available under the "Investors – Presentations & Posters" section of the Company's website, www.rxipharma.com approximately 1 hour following each presentation.
News 
Market Data 
Discover 
